Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone (VITARM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00931125
Recruitment Status : Unknown
Verified October 2013 by Attila Vajas, University of Debrecen.
Recruitment status was:  Active, not recruiting
First Posted : July 2, 2009
Last Update Posted : October 16, 2013
Semmelweis University
Information provided by (Responsible Party):
Attila Vajas, University of Debrecen

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Actual Primary Completion Date : September 2013
  Estimated Study Completion Date : December 2013